Giovanni is Partner of the Biotech Fund at Indaco Venture Partners. He has more than 20 years of experience in drug discovery and development. Previously he led the biology unit of Intercept Pharmaceuticals. He received his Ph. D. in Oncology and his specialization in Microbiology and Virology at the University of Perugia.

He was head of biology of Intercept Pharmaceuticals Inc.; Consultant at Index Ventures (MediXci), a venture capital firm; CEO of iDNA Ltd, a drug discovery service company; Vice President of Yaqrit Ltd, a spin off company of the University College London; Chief of Innovation Division and member of board of directors of Zcube, Zambon group.

Dr. Rizzo is an entrepreneur and an investor himself of the London Business Angels (LBA) association; he holds a board member position in the Italian Angels for Biotech.